Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Reflexive laboratory-based cryptococcal antigen screening and preemptive fluconazole therapy for cryptococcal antigenemia in HIV-infected individuals with CD4 <100 cells/µL: a stepped-wedge, cluster-randomized trial.

Meya DB, Kiragga AN, Nalintya E, Morawski BM, Rajasingham R, Park BJ, Mubiru A, Kaplan JE, Manabe YC, Boulware DR; ORCAS study team.

J Acquir Immune Defic Syndr. 2018 Nov 5. doi: 10.1097/QAI.0000000000001894. [Epub ahead of print]

PMID:
30399034
2.

Complete ciprofloxacin resistance in gonococcal isolates in an urban Ugandan clinic: findings from a cross-sectional study.

Mabonga E, Parkes-Ratanshi R, Riedel S, Nabweyambo S, Mbabazi O, Taylor C, Gaydos C, Manabe YC.

Int J STD AIDS. 2018 Nov 4:956462418799017. doi: 10.1177/0956462418799017. [Epub ahead of print]

PMID:
30392463
3.

Effect of TB/HIV Integration on TB and HIV Indicators in Rural Ugandan Health Facilities.

Burnett SM, Zawedde-Muyanja S, Hermans SM, Weaver MR, Colebunders R, Manabe YC.

J Acquir Immune Defic Syndr. 2018 Dec 15;79(5):605-611. doi: 10.1097/QAI.0000000000001862.

PMID:
30383587
4.

Infectious Diseases Physicians: Improving and Protecting the Public's Health- Why Equitable Compensation is Critical.

Zahn M, Adalja AA, Auwaerter PG, Edelson PJ, Hansen GR, Hynes NA, Jezek A, MacArthur RD, Manabe YC, McGoodwin C, Duchin JS; Infectious Diseases Society of America.

Clin Infect Dis. 2018 Oct 17. doi: 10.1093/cid/ciy888. [Epub ahead of print]

PMID:
30329044
5.

Brief Report: Pulmonary Tuberculosis Is Associated With Persistent Systemic Inflammation and Decreased HIV-1 Reservoir Markers in Coinfected Ugandans.

Olson A, Ragan EJ, Nakiyingi L, Lin N, Jacobson KR, Ellner JJ, Manabe YC, Sagar M.

J Acquir Immune Defic Syndr. 2018 Nov 1;79(3):407-411. doi: 10.1097/QAI.0000000000001823.

PMID:
30063648
6.

Opportunistic diseases diminish the clinical benefit of immediate antiretroviral therapy in HIV-tuberculosis co-infected adults with low CD4+ cell counts.

Worodria W, Ssempijja V, Hanrahan C, Ssegonja R, Muhofwa A, Mazapkwe D, Mayanja-Kizza H, Reynolds SJ, Colebunders R, Manabe YC.

AIDS. 2018 Sep 24;32(15):2141-2149. doi: 10.1097/QAD.0000000000001941.

PMID:
30005014
7.

Challenges of Rapid Plasma Reagin Interpretation in Syphilis Screening in Uganda: Variability in Nontreponemal Results Between Different Laboratories.

Hamill MM, Mbazira KJ, Kiragga AN, Gaydos CA, Jett-Goheen M, Parkes-Ratanshi R, Manabe YC, Nakku-Joloba E, Rompalo A.

Sex Transm Dis. 2018 Dec;45(12):829-833. doi: 10.1097/OLQ.0000000000000883.

PMID:
29944643
8.

The wide utility of rabbits as models of human diseases.

Esteves PJ, Abrantes J, Baldauf HM, BenMohamed L, Chen Y, Christensen N, González-Gallego J, Giacani L, Hu J, Kaplan G, Keppler OT, Knight KL, Kong XP, Lanning DK, Le Pendu J, de Matos AL, Liu J, Liu S, Lopes AM, Lu S, Lukehart S, Manabe YC, Neves F, McFadden G, Pan R, Peng X, de Sousa-Pereira P, Pinheiro A, Rahman M, Ruvoën-Clouet N, Subbian S, Tuñón MJ, van der Loo W, Vaine M, Via LE, Wang S, Mage R.

Exp Mol Med. 2018 May 22;50(5):66. doi: 10.1038/s12276-018-0094-1. Review.

9.

"Tuberculosis in advanced HIV infection is associated with increased expression of IFNγ and its downstream targets".

Verma S, Du P, Nakanjako D, Hermans S, Briggs J, Nakiyingi L, Ellner JJ, Manabe YC, Salgame P.

BMC Infect Dis. 2018 May 15;18(1):220. doi: 10.1186/s12879-018-3127-4.

10.

Vector-Borne Disease is a Common Cause of Hospitalized Febrile Illness in India.

Robinson ML, Kadam D, Khadse S, Balasubramanian U, Raichur P, Valvi C, Marbaniang I, Kanade S, Sachs J, Basavaraj A, Bharadwaj R, Kagal A, Kulkarni V, Zenilman J, Nelson G, Manabe YC, Kinikar A, Gupta A, Mave V.

Am J Trop Med Hyg. 2018 May;98(5):1526-1533. doi: 10.4269/ajtmh.17-0571. Epub 2018 Mar 22.

PMID:
29582731
11.

The utility of pharmacokinetic studies for the evaluation of exposure-response relationships for standard dose anti-tuberculosis drugs.

Sekaggya-Wiltshire C, Lamorde M, Kiragga AN, Dooley KE, Kamya MR, Kambugu A, Fehr J, Manabe YC, Castelnuovo B.

Tuberculosis (Edinb). 2018 Jan;108:77-82. doi: 10.1016/j.tube.2017.11.004. Epub 2017 Nov 7. Review.

PMID:
29523331
12.

Delayed Sputum Culture Conversion in Tuberculosis-Human Immunodeficiency Virus-Coinfected Patients With Low Isoniazid and Rifampicin Concentrations.

Sekaggya-Wiltshire C, von Braun A, Lamorde M, Ledergerber B, Buzibye A, Henning L, Musaazi J, Gutteck U, Denti P, de Kock M, Jetter A, Byakika-Kibwika P, Eberhard N, Matovu J, Joloba M, Muller D, Manabe YC, Kamya MR, Corti N, Kambugu A, Castelnuovo B, Fehr JS.

Clin Infect Dis. 2018 Aug 16;67(5):708-716. doi: 10.1093/cid/ciy179.

PMID:
29514175
13.

Performance of loop-mediated isothermal amplification assay in the diagnosis of pulmonary tuberculosis in a high prevalence TB/HIV rural setting in Uganda.

Nakiyingi L, Nakanwagi P, Briggs J, Agaba T, Mubiru F, Mugenyi M, Ssengooba W, Joloba ML, Manabe YC.

BMC Infect Dis. 2018 Feb 21;18(1):87. doi: 10.1186/s12879-018-2992-1.

14.

Synergistic Impact of Training Followed by On-Site Support on HIV Clinical Practice: A Mixed-Design Study in Uganda With Pre/Post and Cluster-Randomized Trial Components.

Burnett SM, Mubiru N, Imani P, Mbonye MK, Fisher L, Colebunders R, Manabe YC, Weaver MR.

J Acquir Immune Defic Syndr. 2018 Apr 15;77(5):467-475. doi: 10.1097/QAI.0000000000001630.

PMID:
29346184
15.

Antimicrobial Drug Resistance in Blood Culture Isolates at a Tertiary Hospital, Uganda.

Kajumbula H, Fujita AW, Mbabazi O, Najjuka C, Izale C, Akampurira A, Aisu S, Lamorde M, Walwema R, Bahr NC, Meya DB, Boulware DR, Manabe YC.

Emerg Infect Dis. 2018 Jan;24(1):174-175. doi: 10.3201/eid2401.171112.

16.

Antimicrobial Resistance of Sterile Site Infections in Sub-Saharan Africa: A Systematic Review.

Workneh M, Katz MJ, Lamorde M, Cosgrove SE, Manabe YC.

Open Forum Infect Dis. 2017 Oct 6;4(4):ofx209. doi: 10.1093/ofid/ofx209. eCollection 2017 Fall.

17.

Text messaging to decrease tuberculosis treatment attrition in TB-HIV coinfection in Uganda.

Hermans SM, Elbireer S, Tibakabikoba H, Hoefman BJ, Manabe YC.

Patient Prefer Adherence. 2017 Aug 31;11:1479-1487. doi: 10.2147/PPA.S135540. eCollection 2017.

18.

Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial.

Gulick RM, Wilkin TJ, Chen YQ, Landovitz RJ, Amico KR, Young AM, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH, McGowan I, Cottle LM, Andrade A, Marcus C, Klingman KL, Chege W, Rinehart AR, Rooney JF, Andrew P, Salata RA, Siegel M, Manabe YC, Frank I, Ho K, Santana J, Stekler JD, Swaminathan S, McCauley M, Hodder S, Mayer KH.

Ann Intern Med. 2017 Sep 19;167(6):384-393. doi: 10.7326/M17-0520. Epub 2017 Aug 22.

19.

Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults.

Bisson GP, Ramchandani R, Miyahara S, Mngqibisa R, Matoga M, Ngongondo M, Samaneka W, Koech L, Naidoo K, Rassool M, Kirui F, Banda P, Mave V, Kadam D, Leger P, Henestroza G, Manabe YC, Bao J, Kumwenda J, Gupta A, Hosseinipour MC; Adult AIDS Clinical Trials Group A5274 (REMEMBER) Study Team.

AIDS. 2017 Oct 23;31(16):2217-2225. doi: 10.1097/QAD.0000000000001606.

20.

Reducing Uncertainty for Acute Febrile Illness in Resource-Limited Settings: The Current Diagnostic Landscape.

Robinson ML, Manabe YC.

Am J Trop Med Hyg. 2017 Jun;96(6):1285-1295. doi: 10.4269/ajtmh.16-0667. Review.

21.

Treatment decisions and mortality in HIV-positive presumptive smear-negative TB in the Xpert™ MTB/RIF era: a cohort study.

Hermans SM, Babirye JA, Mbabazi O, Kakooza F, Colebunders R, Castelnuovo B, Sekaggya-Wiltshire C, Parkes-Ratanshi R, Manabe YC.

BMC Infect Dis. 2017 Jun 16;17(1):433. doi: 10.1186/s12879-017-2534-2.

22.

Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohorts.

Montgomery MP, Nakasujja N, Morawski BM, Rajasingham R, Rhein J, Nalintya E, Williams DA, Huppler Hullsiek K, Kiragga A, Rolfes MA, Donahue Carlson R, Bahr NC, Birkenkamp KE, Manabe YC, Bohjanen PR, Kaplan JE, Kambugu A, Meya DB, Boulware DR; COAT and ORCAS Trial Teams.

BMC Neurol. 2017 Jun 12;17(1):110. doi: 10.1186/s12883-017-0878-2.

23.

Immune Reconstitution Inflammatory Syndrome (IRIS): What pathologists should know.

Nelson AM, Manabe YC, Lucas SB.

Semin Diagn Pathol. 2017 Jul;34(4):340-351. doi: 10.1053/j.semdp.2017.04.010. Epub 2017 Apr 26. Review.

PMID:
28552210
24.

Premature Coronary Artery Disease and ST-Elevation Myocardial Infarction in a 24-Year-Old Man With Perinatally Acquired Human Immunodeficiency Virus: A Case Report.

Griffith DC, Aronis KN, Orozco AM, Traill TA, Manabe YC, Agwu AL.

Open Forum Infect Dis. 2017 Feb 10;4(1):ofw260. doi: 10.1093/ofid/ofw260. eCollection 2017 Winter.

25.

Anti-TB drug concentrations and drug-associated toxicities among TB/HIV-coinfected patients.

Sekaggya-Wiltshire C, von Braun A, Scherrer AU, Manabe YC, Buzibye A, Muller D, Ledergerber B, Gutteck U, Corti N, Kambugu A, Byakika-Kibwika P, Lamorde M, Castelnuovo B, Fehr J, Kamya MR.

J Antimicrob Chemother. 2017 Apr 1;72(4):1172-1177. doi: 10.1093/jac/dkw534.

26.

Prevention of Early Mortality by Presumptive Tuberculosis Therapy Study: An Open Label, Randomized Controlled Trial.

Manabe YC, Worodria W, van Leth F, Mayanja-Kizza H, Traore AN, Ferro J, Pakker N, Frank M, Grobusch MP, Colebunders R, Cobelens F.

Am J Trop Med Hyg. 2016 Dec 7;95(6):1265-1271. Epub 2016 Oct 17.

27.
28.

Effect of On-Site Support on Laboratory Practice for Human Immunodeficiency Virus, Tuberculosis, and Malaria Testing.

Burnett SM, Mbonye MK, Martin R, Ronald A, Zawedde-Muyanja S, Willis KS, Colebunders R, Manabe YC, Weaver MR.

Am J Clin Pathol. 2016 Oct;146(4):469-77. doi: 10.1093/ajcp/aqw138.

PMID:
27686173
29.

Training tomorrow's leaders in global health: impact of the Afya Bora Consortium Fellowship on the careers of its alumni.

Monroe-Wise A, Mashalla Y, O'Malley G, Nathanson N, Seloilwe E, Gachuno O, Odero T, Nakanjako D, Sewankambo N, Tarimo E, Urassa D, Manabe YC, Chapman S, Voss JG, Wasserheit J, Farquhar C; Afya Bora Consortium Working Group.

BMC Med Educ. 2016 Sep 19;16(1):241. doi: 10.1186/s12909-016-0750-x.

30.

Clinical Evaluation of 2 Point-of-Care Lateral Flow Tests for the Diagnosis of Syphilis.

Nakku-Joloba E, Kiragga A, Mbazira JK, Kambugu F, Jett-Goheen M, Ratanshi RP, Gaydos C, Manabe YC.

Sex Transm Dis. 2016 Oct;43(10):623-5. doi: 10.1097/OLQ.0000000000000498.

31.

Accelerating the Uptake and Timing of Antiretroviral Therapy Initiation in Sub-Saharan Africa: An Operations Research Agenda.

Rosen S, Fox MP, Larson BA, Sow PS, Ehrenkranz PD, Venter F, Manabe YC, Kaplan J; Models for Accelerating Treatment Initiation (MATI) Technical Consultation.

PLoS Med. 2016 Aug 9;13(8):e1002106. doi: 10.1371/journal.pmed.1002106. eCollection 2016 Aug.

32.

Implementation and Operational Research: Impact of Nurse-Targeted Care on HIV Outcomes Among Immunocompromised Persons: A Before-After Study in Uganda.

Kiragga AN, Nalintya E, Morawski BM, Kigozi J, Park BJ, Kaplan JE, Boulware DR, Meya DB, Manabe YC.

J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):e32-6. doi: 10.1097/QAI.0000000000001002.

33.

Depressive and Anxiety Symptoms Predict Sustained Quality of Life Deficits in HIV-Positive Ugandan Adults Despite Antiretroviral Therapy: A Prospective Cohort Study.

Ezeamama AE, Woolfork MN, Guwatudde D, Bagenda D, Manabe YC, Fawzi WW, Smith Fawzi MC.

Medicine (Baltimore). 2016 Mar;95(9):e2525. doi: 10.1097/MD.0000000000002525.

34.

High perceived social standing is associated with better health in HIV-infected Ugandan adults on highly active antiretroviral therapy.

Ezeamama AE, Guwatudde D, Wang M, Bagenda D, Brown K, Kyeyune R, Smith E, Wamani H, Manabe YC, Fawzi WW.

J Behav Med. 2016 Jun;39(3):453-64. doi: 10.1007/s10865-015-9710-x. Epub 2016 Jan 5.

PMID:
26733010
35.

Reply to "A Word of Caution in Considering the Use of the Lipoarabinomannan Lateral Flow Assay on Cerebrospinal Fluid for Detection of Tuberculous Meningitis".

Cox JA, Colebunders R, Manabe YC.

J Clin Microbiol. 2016 Jan;54(1):243. doi: 10.1128/JCM.02823-15. No abstract available.

36.

The immunopathogenesis of cryptococcal immune reconstitution inflammatory syndrome: understanding a conundrum.

Meya DB, Manabe YC, Boulware DR, Janoff EN.

Curr Opin Infect Dis. 2016 Feb;29(1):10-22. doi: 10.1097/QCO.0000000000000224. Review.

37.

Prevalence and predictors of prior antibacterial use among patients presenting to hospitals in Northern Uganda.

Ocan M, Manabe YC, Baluku H, Atukwase E, Ogwal-Okeng J, Obua C.

BMC Pharmacol Toxicol. 2015 Sep 25;16:26. doi: 10.1186/s40360-015-0027-8.

38.

Vitamin-D deficiency impairs CD4+T-cell count recovery rate in HIV-positive adults on highly active antiretroviral therapy: A longitudinal study.

Ezeamama AE, Guwatudde D, Wang M, Bagenda D, Kyeyune R, Sudfeld C, Manabe YC, Fawzi WW.

Clin Nutr. 2016 Oct;35(5):1110-7. doi: 10.1016/j.clnu.2015.08.007. Epub 2015 Sep 5.

39.

Effect of Educational Outreach Timing and Duration on Facility Performance for Infectious Disease Care in Uganda: A Trial with Pre-Post and Cluster Randomized Controlled Components.

Burnett SM, Mbonye MK, Naikoba S, Zawedde-Muyanja S, Kinoti SN, Ronald A, Rubashembusya T, Willis KS, Colebunders R, Manabe YC, Weaver MR.

PLoS One. 2015 Sep 9;10(9):e0136966. doi: 10.1371/journal.pone.0136966. eCollection 2015.

40.

The effect of standard dose multivitamin supplementation on disease progression in HIV-infected adults initiating HAART: a randomized double blind placebo-controlled trial in Uganda.

Guwatudde D, Wang M, Ezeamama AE, Bagenda D, Kyeyune R, Wamani H, Manabe YC, Fawzi WW.

BMC Infect Dis. 2015 Aug 19;15:348. doi: 10.1186/s12879-015-1082-x.

41.

Estimating the Public Health Burden Associated With Adverse Pregnancy Outcomes Resulting From Syphilis Infection Across 43 Countries in Sub-Saharan Africa.

Kuznik A, Habib AG, Manabe YC, Lamorde M.

Sex Transm Dis. 2015 Jul;42(7):369-75. doi: 10.1097/OLQ.0000000000000291.

42.

Predictors for MTB Culture-Positivity among HIV-Infected Smear-Negative Presumptive Tuberculosis Patients in Uganda: Application of New Tuberculosis Diagnostic Technology.

Nakiyingi L, Nonyane BA, Ssengooba W, Kirenga BJ, Nakanjako D, Lubega G, Byakika-Kibwika P, Joloba ML, Ellner JJ, Dorman SE, Mayanja-Kizza H, Manabe YC.

PLoS One. 2015 Jul 29;10(7):e0133756. doi: 10.1371/journal.pone.0133756. eCollection 2015.

43.

High Genotypic Discordance of Concurrent Mycobacterium tuberculosis Isolates from Sputum and Blood of HIV-Infected Individuals.

Ssengooba W, Cobelens FG, Nakiyingi L, Mboowa G, Armstrong DT, Manabe YC, Joloba ML, de Jong BC.

PLoS One. 2015 Jul 15;10(7):e0132581. doi: 10.1371/journal.pone.0132581. eCollection 2015.

44.

Cryptococcal Antigen Screening and Preemptive Treatment in a US Cohort of Patients With AIDS.

Manabe YC, Moore RD.

Clin Infect Dis. 2015 Nov 15;61(10):1632-4. doi: 10.1093/cid/civ559. Epub 2015 Jul 13. No abstract available.

45.

Accuracy of Lipoarabinomannan and Xpert MTB/RIF Testing in Cerebrospinal Fluid To Diagnose Tuberculous Meningitis in an Autopsy Cohort of HIV-Infected Adults.

Cox JA, Lukande RL, Kalungi S, Van Marck E, Lammens M, Van de Vijver K, Kambugu A, Nelson AM, Colebunders R, Manabe YC.

J Clin Microbiol. 2015 Aug;53(8):2667-73. doi: 10.1128/JCM.00624-15. Epub 2015 Jun 10.

46.

Rapid improvement in passive tuberculosis case detection and tuberculosis treatment outcomes after implementation of a bundled laboratory diagnostic and on-site training intervention targeting mid-level providers.

Manabe YC, Zawedde-Muyanja S, Burnett SM, Mugabe F, Naikoba S, Coutinho A.

Open Forum Infect Dis. 2015 Mar 31;2(1):ofv030. doi: 10.1093/ofid/ofv030. eCollection 2015 Jan.

47.

Is Urinary Lipoarabinomannan the Result of Renal Tuberculosis? Assessment of the Renal Histology in an Autopsy Cohort of Ugandan HIV-Infected Adults.

Cox JA, Lukande RL, Kalungi S, Van Marck E, Van de Vijver K, Kambugu A, Nelson AM, Colebunders R, Manabe YC.

PLoS One. 2015 Apr 21;10(4):e0123323. doi: 10.1371/journal.pone.0123323. eCollection 2015.

48.

Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda.

Nakiyingi L, Ssengooba W, Nakanjako D, Armstrong D, Holshouser M, Kirenga BJ, Shah M, Mayanja-Kizza H, Joloba ML, Ellner JJ, Dorman SE, Manabe YC.

BMC Infect Dis. 2015 Feb 15;15:62. doi: 10.1186/s12879-015-0812-4.

49.

Implementation and operational research: Integrated pre-antiretroviral therapy screening and treatment for tuberculosis and cryptococcal antigenemia.

Pac L, Horwitz MM, Namutebi AM, Auerbach BJ, Semeere A, Namulema T, Schwarz M, Bbosa R, Muruta A, Meya DB, Manabe YC.

J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):e69-76. doi: 10.1097/QAI.0000000000000527.

50.

Improving the sensitivity of the Xpert MTB/RIF assay on sputum pellets by decreasing the amount of added sample reagent: a laboratory and clinical evaluation.

Dharan NJ, Amisano D, Mboowa G, Ssengooba W, Blakemore R, Kubiak RW, Armstrong DT, Jones M, Manabe YC, Joloba ML, Ellner JJ, Dorman SE, Alland D.

J Clin Microbiol. 2015 Apr;53(4):1258-63. doi: 10.1128/JCM.03619-14. Epub 2015 Feb 4.

Supplemental Content

Loading ...
Support Center